3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Rectal Neoplasms
5
Lung Neoplasms
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma Of Esophagus
4
Colonic Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms, Male
3
Brain Neoplasms
3
Sarcoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Breast Carcinoma In Situ
2
Vomiting
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Radiation Injuries
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Nausea
1
Medulloblastoma
1
Interventions
aldesleukin
15
Cyclophosphamide
15
fludarabine phosphate
12
fludarabine
11
Interleukin-2
10
Nivolumab
6
Ipilimumab
6
Temozolomide
5
pembrolizumab
3
Fluorouracil
3
trametinib
2
sonidegib
2
dabrafenib
2
binimetinib
2
Whole-Body Irradiation
2
Vemurafenib
2
Tacrolimus
2
Sodium Chloride
2
Sirolimus
2
Radiotherapy
2
Radiation
2
Peptides
2
HhAntag691
2
Gefitinib
2
Dacarbazine
2
Cyclosporine
2
Cetuximab
2
Capecitabine
2
veliparib
1
varlilumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Skin Neoplasms
×
Chemotherapy, Adjuvant
×
Clear all
No trials found.